Search Within

Guido Dalbagni

  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (45)
  3. Correspondence (4)
  4. Review (2)
  5. Book Section (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (102)
  2. Genitourinary Oncology Service (102)
  3. Solid Tumor Oncology Division (102)
  4. Surgery (102)
  5. Urology (102)
  6. Department of Pathology and Laboratory Medicine (75)

More Groups

People
  1. Bernard Bochner (82)
  2. Dean Bajorin (80)
  3. Hikmat Al-Ahmadie (64)
  4. Gopakumar Iyer (62)
  5. Jonathan Rosenberg (62)
  6. David Solit (51)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (8)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Modern Pathology (10)
  3. Journal of Urology (9)
  4. Laboratory Investigation (9)
  5. Cancer (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. Elsevier Science, Inc. (14)
  3. Nature Publishing Group (11)
  4. Elsevier Inc. (10)
  5. Nature Research (10)
  6. American Association for Cancer Research (8)

More Publishers

Results (102)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Upper tract urothelial carcinoma: Genetic characteristics and correlation with morphology and clinical outcomes
    Meeting Abstract

    Ren, Q.; Sfakianos, J.; Cha, E.; Iyer, G.; Scott, S.; Shah, R.; Kim, P.; Desai, N.; Bagrodia, A.; Gandhi, A.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Image-guided intensity modulated radiation therapy (IMRT) for bladder cancer: Toxicity and early outcomes
    Meeting Abstract

    Kollmeier, M. A.; Thakker, N.; Zelefsky, M. J.; Bochner, B. H.; Dalbagni, G.; Bajorin, D. F.; Rosenberg, J. E.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND
    Meeting Abstract

    Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeted sequencing of upper tract urothelial carcinoma
    Meeting Abstract

    Sfakianos, J. P.; Kim, P. H.; Iyer, G.; Cha, E. K.; Zabor, E. C.; Hakimi, A. A.; Scott, S. N.; Ramirez, R.; Hanrahan, A.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets
    Meeting Abstract

    Kim, P. H.; Sfakianos, J. P.; Scott, S. N.; Iyer, G.; Cha, E. K.; Al-Ahmadie, H.; Sun, A. J.; Garcia-Grossman, I. R.; Bambury, R. M.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Journal Article

    Kim, P. H.; Kent, M.; Zhao, P.; Sfakianos, J. P.; Bajorin, D. F.; Bochner, B. H.; Dalbagni, G.
    World Journal of Urology (2014)

    Fulltext@MSK | Save
  • Her2 expression in urothelial carcinoma with micropapillary morphology: Preferential overexpresssion by the micropapillary component
    Meeting Abstract

    Huang, H.; Jadallah, S.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Iyer, G. V.; Dalbagni, G.; Solit, D.; Reuter, V. E.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Her2 expression in urothelial carcinoma with micropapillary morphology: Preferential overexpresssion by the micropapillary component
    Meeting Abstract

    Huang, H.; Jadallah, S.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Iyer, G. V.; Dalbagni, G.; Solit, D.; Reuter, V. E.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • E-cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • E-Cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save